FDA Approves ITRACONAZOLE — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals received approval for generic itraconazole (ANDA 205080) on September 26, 2016, which expands access to this antifungal oral medication and expected to initiate market entry shortly after the generic launch. The approval is projected to heighten competitive pressure in the oral antifungal market, increasing supply options for patients.